VSEE HEALTH, INC. Faces Delisting Concerns

TL;DR

VSEE HEALTH facing delisting issues, filing 8-K on 8/20/25.

AI Summary

VSEE HEALTH, INC. filed an 8-K on August 22, 2025, reporting a notice of delisting or failure to satisfy continued listing rules, a Regulation FD disclosure, and financial statements. The earliest event reported was August 20, 2025. The company was formerly known as DIGITAL HEALTH ACQUISITION CORP. and changed its name on May 26, 2021.

Why It Matters

This filing indicates potential issues with VSEE HEALTH, INC.'s continued listing on an exchange, which could significantly impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can lead to severe stock price declines and reduced liquidity.

Key Players & Entities

• VSEE HEALTH, INC. (company) — Registrant
• August 20, 2025 (date) — Earliest event reported
• August 22, 2025 (date) — Filing date
• DIGITAL HEALTH ACQUISITION CORP. (company) — Former company name
• May 26, 2021 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
• $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St

Filing Documents

• tm2524183d1_8k.htm (8-K) — 37KB
• tm2524183d1_ex99-1.htm (EX-99.1) — 8KB
• 0001104659-25-081950.txt ( ) — 255KB
• vsee-20250820.xsd (EX-101.SCH) — 3KB
• vsee-20250820_def.xml (EX-101.DEF) — 26KB
• vsee-20250820_lab.xml (EX-101.LAB) — 36KB
• vsee-20250820_pre.xml (EX-101.PRE) — 25KB
• tm2524183d1_8k_htm.xml (XML) — 5KB

01. Regulation

Item 7.01. Regulation FD Disclosure. On August 22, 2025, the Company issued a press release regarding receipt of the Staff letter. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the U.S. federal securities laws.

Forward-looking statements can be identified by words such as "projects," "may," "will," "could,"

Forward-looking statements can be identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential," "promise" or similar references to future periods. Examples of forward-looking statements in this current report include, without limitation, statements regarding the Company's available options to resolve the deficiency and regain compliance with Nasdaq listing rules. Forward-looking statements are statements that are not historical facts nor assurances of future performance. Instead, they are based on the Company's current beliefs, expectations, and assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties, and actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual results to differ include, without limitation, that there can be no assurance that the Company will file the late periodic reports, that there can be no assurance that the Company will otherwise meet Nasdaq compliance standards, that there can be no assurance that Nasdaq will grant the Company any relief from delisting as necessary or whether the Company can agree to or ultimately meet applicable Nasdaq requirements for any such relief, and the other important factors described under the caption "Risk Factors" in the Company's filings with the SEC. Any forward-looking statement made by the Company in this current report is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whethe

01. Financial

Item 9.01. Financial (d) Exhibits. Exhibit No. Description 99.1 Press Release of the Company dated August 22, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 22, 2025 VSEE HEALTH, INC. By: /s/ Imoigele Aisiku Name: Imoigele Aisiku Title: Co-Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR